• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Ophthalmology AI platform LumineticsCore™
diagnostic

Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic - image - 2
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic - image - 3
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic - image - 4
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic - image - 5
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic - image - 6
Ophthalmology AI platform - LumineticsCore™ - Digital Diagnostics - diagnostic - image - 7
Add to favorites
Compare this product
 

Characteristics

Application domain
ophthalmology
Function
diagnostic

Description

LumineticsCore is an Al diagnostic system that autonomously diagnoses diabetic retinopathy (including macular edema) in people living with diabetes. Diagnostic results at the point-of-care No need for specialist overread or telemedicine call backs A simple user interface Customized workflow integration solutions The Problem: Every Year, Over 60,000 People Go Blind from Diabetic Retinopathy How LumineticsCore Works 1 Using a fundus camera, the trained operator captures two images per eye 2 The images are submitted to LumineticsCore 3 LumineticsCore analyzes images for signs of diabetic retinopathy (including macular edema), providing results in less than a minute Results No diabetic retinopathy detected: Retest in 12 Months Results Diabetic retinopathy detected: Refer to an eye care professional Our Approach to AI Driven Diagnostics AI the Right Way™ LumineticsCore™ is modeled to look for and make decisions based on the same clinical disease detectors that eye care specialists would use. Diagnostic AI built on an ethical foundation Diagnostic results at the point-of-care Infinitely scalable High Performance in a Real-World Clinical Setting Safety LumineticsCore was validated against patient outcomes using a surrogate outcome standard to keep patient safety the main priority. Effective In our pivotal clinical trial, LumineticsCore avoided 91% of unnecessary specialty visits by providing a diagnostic result that is negative for diabetic retinopathy (including macular edema) at the point-of-care.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.